top of page

The GLP-1 Revolution: More Than Just a Weight Loss Trend


By Mohsen Halaby, MD

Board-Certified Internal Medicine

Carebridge Medical | Serving Ohio


Glucagon-like peptide-1 (GLP-1) medications have rapidly transformed the way we treat obesity and type 2 diabetes. What started as a diabetes therapy has evolved into one of the most significant breakthroughs in metabolic medicine in decades.

But what exactly is GLP-1? And why is it such a big deal?

What Is GLP-1?

GLP-1 is a naturally occurring gut hormone released after eating. It plays a powerful role in metabolic regulation by:

  • Stimulating insulin secretion

  • Suppressing glucagon

  • Slowing gastric emptying

  • Reducing appetite via brain signaling

GLP-1 receptor agonists are medications designed to mimic and amplify these natural effects.

FDA-Approved GLP-1 Medications

Some of the most well-known GLP-1–based therapies include:

  • Semaglutide (brand names include Ozempic® and Wegovy®)

  • Tirzepatide (brand names include Mounjaro® and Zepbound®)

  • Liraglutide (brand names include Victoza® and Saxenda®)

Tirzepatide is technically a dual GIP/GLP-1 receptor agonist, which may explain its even greater weight loss effect in clinical trials.

How Effective Are They?

Clinical trials show:

  • 10–15% average body weight loss with semaglutide

  • 15–22% average weight loss with tirzepatide

  • Significant improvement in A1c for patients with type 2 diabetes

  • Reduction in cardiovascular risk in high-risk patients

These results approach outcomes previously seen only with bariatric surgery.

Beyond Weight Loss

GLP-1 medications are now being studied for:

  • Cardiovascular protection

  • Fatty liver disease (MASLD)

  • Sleep apnea

  • Kidney protection

  • Possibly neuroprotective effects

This suggests GLP-1 therapy may be part of a broader metabolic disease strategy — not just a cosmetic weight solution.

Common Side Effects

Most side effects are gastrointestinal and dose-dependent:

  • Nausea

  • Vomiting

  • Constipation

  • Bloating

These are usually temporary and can be minimized with slow dose titration.

Rare but important considerations include:

  • History of medullary thyroid carcinoma

  • History of pancreatitis

A thorough medical evaluation is essential before starting therapy.

Who Is a Good Candidate?

GLP-1 therapy may be appropriate for:

  • BMI ≥30

  • BMI ≥27 with obesity-related conditions (hypertension, diabetes, sleep apnea)

  • Patients with type 2 diabetes needing better glycemic control

  • Individuals who have struggled with traditional lifestyle-based weight loss

GLP-1 medications work best when combined with nutrition guidance, strength training, sleep optimization, and long-term medical follow-up.

The Future of Metabolic Medicine

We are entering an era where obesity is increasingly treated as a chronic metabolic disease rather than a failure of willpower. GLP-1 therapies represent a shift toward biologically targeted, evidence-based treatment.

When prescribed responsibly and monitored appropriately, these medications can be transformative.

How We Approach GLP-1 Therapy

At Carebridge, we evaluate each patient individually before initiating medical weight management. Our approach includes:

  • Comprehensive metabolic review

  • Risk stratification

  • Ongoing monitoring

  • Personalized lifestyle guidance

GLP-1 therapy is not a shortcut — it’s a tool. The goal is sustainable metabolic health, not temporary weight loss.


GLP-1 Therapy at Carebridge

At Carebridge, medical weight management is physician-led and evidence-based. We do not treat weight loss as a cosmetic service — we treat metabolic disease.

Our GLP-1 program includes:

  • Comprehensive medical evaluation

  • Review of labs and metabolic risk factors

  • Medications selection based on clinical profile

  • Structured dose titration and side-effect monitoring

  • Ongoing virtual follow-up

  • Nutrition and lifestyle guidance

Carebridge provides virtual care to adult patients in Ohio offering convenient access to board-certified internal medicine oversight without the delays of traditional clinics.

Our goal is long-term metabolic health — not rapid, unsupervised weight loss.

Want to Learn More?

If you’re interested in physician-supervised medical weight management, including GLP-1 therapy, schedule a consultation with Carebridge today.

Disclaimer

This article is for educational purposes only and does not constitute medical advice. GLP-1 medications require medical evaluation and prescription. Individual results vary. Consult a qualified healthcare professional before starting any treatment.

Comments


Accepting patients in OH, MI & CA

Carebridge Medical

Primary Care | Metabolic Health | Weight Loss

Dr. Mohsen Halaby, MD

Board-Certified Internal Medicine Physician 

Personalized modern medical care

Virtual care available now in Ohio, Michigan & California

In-person care opening July 2026 at: 9400 N McCord Rd, Suite A-1B, Sylvania, OH 43560

✔ Transparent self-pay pricing
✔ No insurance required
✔ Select insurance coming soon

Legal
Privacy Policy
Terms of Use
HIPAA Notice

Carebridge Medical provides virtual and in-person healthcare services and is not a substitute for emergency medical care. If you are experiencing a medical emergency, call 911 or go to the nearest emergency room.

© 2026 carebridge medical. All rights reserved.
Independent physician-owned practice. Not affiliated with other Carebridge entities.

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
bottom of page